TF and ovarian cancer: Our finding that 6-OSulfo-TF but not its non-sulfated analogue TF, was (apart from CA125) the second-best HGSOC from control discriminator is noteworthy, because the role of glycan sulfation (in contrast to glycan sialylation) has not yet been studied in ovarian cancer.